202 related articles for article (PubMed ID: 34355280)
21. A STUDY OF CATASTROPHIC HEALTH EXPENDITURES IN INDIA - EVIDENCE FROM NATIONALLY REPRESENTATIVE SURVEY DATA: 2014-2018.
Sriram S; Albadrani M
F1000Res; 2022; 11():141. PubMed ID: 35464045
[No Abstract] [Full Text] [Related]
22. Assessing progress towards universal health coverage in Cambodia: Evidence using survey data from 2009 to 2019.
Kaiser AH; Okorafor O; Ekman B; Chhim S; Yem S; Sundewall J
Soc Sci Med; 2023 Mar; 321():115792. PubMed ID: 36842307
[TBL] [Abstract][Full Text] [Related]
23. Households forgoing healthcare as a measure of financial risk protection: an application to Liberia.
Gabani J; Guinness L
Int J Equity Health; 2019 Dec; 18(1):193. PubMed ID: 31823823
[TBL] [Abstract][Full Text] [Related]
24. Measuring the economic burden for TB patients in the End TB Strategy and Universal Health Coverage frameworks.
Pedrazzoli D; Borghi J; Viney K; Houben RMGJ; Lönnroth K
Int J Tuberc Lung Dis; 2019 Jan; 23(1):5-11. PubMed ID: 30674374
[TBL] [Abstract][Full Text] [Related]
25. Progress on catastrophic health spending in 133 countries: a retrospective observational study.
Wagstaff A; Flores G; Hsu J; Smitz MF; Chepynoga K; Buisman LR; van Wilgenburg K; Eozenou P
Lancet Glob Health; 2018 Feb; 6(2):e169-e179. PubMed ID: 29248367
[TBL] [Abstract][Full Text] [Related]
26. Economic impacts of chronic conditions in a country with high levels of population health coverage: lessons from Mongolia.
Dugee O; Sugar B; Dorjsuren B; Mahal A
Trop Med Int Health; 2019 Jun; 24(6):715-726. PubMed ID: 30870575
[TBL] [Abstract][Full Text] [Related]
27. On the Measurement of Financial Protection: An Assessment of the Usefulness of the Catastrophic Health Expenditure Indicator to Monitor Progress Towards Universal Health Coverage.
Grépin KA; Irwin BR; Sas Trakinsky B
Health Syst Reform; 2020 Dec; 6(1):e1744988. PubMed ID: 33416439
[TBL] [Abstract][Full Text] [Related]
28. Financial Protection in Health among the Elderly - A Global Stocktake.
Eozenou PH; Neelsen S; Smitz MF
Health Syst Reform; 2021 Jul; 7(2):e1911067. PubMed ID: 34402386
[TBL] [Abstract][Full Text] [Related]
29. A new hope: from neglect of the health sector to aspirations for Universal Health Coverage in Myanmar.
Ergo A; Htoo TS; Badiani-Magnusson R; Royono R
Health Policy Plan; 2019 Oct; 34(Supplement_1):i38-i46. PubMed ID: 31644797
[TBL] [Abstract][Full Text] [Related]
30. Assessment of out-of-pocket and catastrophic expenses incurred by patients with Human Immunodeficiency Virus (HIV) in availing free antiretroviral therapy services in India.
Alvi Y; Faizi N; Khalique N; Ahmad A
Public Health; 2020 Jun; 183():16-22. PubMed ID: 32413804
[TBL] [Abstract][Full Text] [Related]
31. Out-of-pocket expenditure for hospitalization in Haryana State of India: Extent, determinants & financial risk protection.
Sharma D; Prinja S; Aggarwal AK; Bahuguna P; Sharma A; Rana SK
Indian J Med Res; 2017 Dec; 146(6):759-767. PubMed ID: 29664035
[TBL] [Abstract][Full Text] [Related]
32. Catastrophic health spending in Europe: equity and policy implications of different calculation methods.
Cylus J; Thomson S; Evetovits T
Bull World Health Organ; 2018 Sep; 96(9):599-609. PubMed ID: 30262941
[TBL] [Abstract][Full Text] [Related]
33. Effects of Out-of-Pocket Medicine's Spending on Catastrophic Expenditure and Impoverishment in Tunisia.
Ismaïl S; Arfa C
Value Health Reg Issues; 2022 Jul; 30():109-118. PubMed ID: 35339767
[TBL] [Abstract][Full Text] [Related]
34. The impact of health reform on poverty estimates in Iran: Implications for monitoring the first goal of Sustainable Development Goals.
Ahmadnezhad E; Dastan I; Alvandi R; Abdi Z
Int J Health Plann Manage; 2023 May; 38(3):747-758. PubMed ID: 36862573
[TBL] [Abstract][Full Text] [Related]
35. Has the Financial Protection Been Materialized in Iranian Health System? Analyzing Household Income and Expenditure Survey 2003-2014.
Ghiasvand H; Olyaeemanesh A; Majdzadeh R; Abdi Z; Mobinizadeh M
J Res Health Sci; 2018 Jan; 18(1):e00404. PubMed ID: 29445050
[TBL] [Abstract][Full Text] [Related]
36. Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran.
Zarei L; Moradi N; Peiravian F; Hatami-Mazinani N; Mahi-Birjand M; Arabloo J; Babar ZU
Int J Equity Health; 2022 Dec; 21(1):188. PubMed ID: 36581933
[TBL] [Abstract][Full Text] [Related]
37. Financial protection in health in Turkey: the effects of the Health Transformation Programme.
Yardim MS; Cilingiroglu N; Yardim N
Health Policy Plan; 2014 Mar; 29(2):177-92. PubMed ID: 23411120
[TBL] [Abstract][Full Text] [Related]
38. Identifying priorities for research on financial risk protection to achieve universal health coverage: a scoping overview of reviews.
Bhatia D; Mishra S; Kirubarajan A; Yanful B; Allin S; Di Ruggiero E
BMJ Open; 2022 Mar; 12(3):e052041. PubMed ID: 35264342
[TBL] [Abstract][Full Text] [Related]
39. Catastrophic health care expenditure in Myanmar: policy implications in leading progress towards universal health coverage.
Myint CY; Pavlova M; Groot W
Int J Equity Health; 2019 Jul; 18(1):118. PubMed ID: 31362749
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
